Managing your cholesterol may also help you manage your prostate- specific antigen (PSA) level. Data presented today at the 103rd Annual Scientific Meeting of the American Urological Association explored the relationship between low-density lipoprotein (LDL) cholesterol and PSA prior to beginning statin therapy.
Get the full story...
The American Diabetes Association (ADA) and the American College of Cardiology (ACC) issued a consensus statement today that states the measurement of LDL particle number by nuclear magnetic resonance (NMR) is one of the more accurate ways to evaluate cardiometabolic risk (CMR).
Get the full story...
A recent study published in the Journal of Agriculture and Food Chemistry found that pomegranate juice from the California-grown Wonderful variety of pomegranate is the leader in the healthy beverage category by demonstrating the most complete free radical scavenging activity, greater protection of LDL-cholesterol from oxidation, and the highest polyphenol content compared to red wine and several juices.
Get the full story...
Low-density lipoprotein (LDL), a transporter of cholesterol, may also contribute to vascular diseases by a previously unidentified mechanism, according to a report published online this week in EMBO reports.
Get the full story...
Good cholesterol, renowned for its ability to protect against heart disease, can undergo detrimental changes in protein composition that make it ‘bad’ for the heart, according to a new laboratory study by researchers in Seattle, Wash.
Get the full story...
A team of researchers investigating cholesterol and lipid transport has performed experiments that cast serious doubt on the dominant hypothesis of how the body rids its cells of "bad" cholesterol (LDL) and increases "good" cholesterol (HDL).
Get the full story...
Women are significantly less likely than men to have their LDL cholesterol controlled to recommended levels, according to a new study by the National Committee for Quality Assurance (NCQA).
Get the full story...
Researchers are sufficiently worried by new study results that they are planning clinical trials involving thousands of people to examine the possible link between Parkinson's disease and statins, the world biggest selling drugs, reports Patrick Walter in Chemistry & Industry, the magazine of the SCI.
Read the full story